EuroIntervention PCRonline - Connecting with the community

Ron Waksman

28 articles

Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model

EuroIntervention 2017;13:440-449 published online March 2017

Published in Volume 13 Number 4, July 2017

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

EuroIntervention 2017;13:432-439 published online ahead of print May 2017

Published in Volume 13 Number 4, July 2017

Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?

EuroIntervention 2017;12:2025-2027 published online December 2016

Published in Volume 12 Number 16, March 2017

Chipping of calcified plaques by orbital atherectomy systems, but holding approval tight: is the FDA moving faster than the European CE agency? A North American perspective

EuroIntervention 2016;12:1083-1086

Published in Volume 12 Number 9, October 2016

Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016

EuroIntervention 2016;12:828-833

Published in Volume 12 Number 7, September 2016

Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

EuroIntervention 2016;12:e160-e166 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement

EuroIntervention 2016;12:88-93

Published in Volume 12 Number 1, May 2016

The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drug-eluting stent era

EuroIntervention 2015;11:625-633

Published in Volume 11 Number 6, October 2015

Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch

EuroIntervention 2015;11:163-170

Published in Volume 11 Number 2, June 2015

The current status of drug-coated balloons in percutaneous coronary and peripheral interventions

EuroIntervention 2013;9:979-988

Published in Volume 9 Number 8, December 2013

Beta radiation for renal nerve denervation: initial feasibility and safety

EuroIntervention 2013;9:738-744

Published in Volume 9 Number 6, October 2013

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial

EuroIntervention 2013;9:613-619

Published in Volume 9 Number 5, September 2013

Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model

EuroIntervention 2013;8:1441-1450

Published in Volume 8 Number 12, April 2013

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

EuroIntervention 2013;8:1006-1011

Published in Volume 8 Number 9, January 2013

The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment

EuroIntervention 2011;7:705-710 publish online ahead of print August 2011

Published in Volume 7 Number 6, October 2011

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis

EuroIntervention 2011;7:225-233

Published in Volume 7 Number 2, June 2011

Intravascular ultrasound predictors of no-reflow after percutaneous saphenous vein graft intervention with distal protection devices

Published in Volume 7 Supplement M, May 2011

First-in-man experience with the DES Orsiro in the treatment of patients with single de novo coronary artery lesions (BIOFLOW-I)

Published in Volume 7 Supplement M, May 2011

Replacement of heparin with bivalirudin does not change outcomes after coronary perforation related to PCI

Published in Volume 7 Supplement M, May 2011

Impact of drug-eluting stent type on periprocedural myocardial necrosis

EuroIntervention 2011;7:136-142

Published in Volume 7 Number 1, May 2011

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

EuroIntervention 2011;6:1085-1090

Published in Volume 6 Number 9, April 2011

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

EuroIntervention 2011;6:1053-1059

Published in Volume 6 Number 9, April 2011

Vascular brachytherapy: a landmark chapter in the field of interventional cardiology

EuroIntervention 2011;6:669-671

Published in Volume 6 Number 6, January 2011

Is there still a role for intravascular ultrasound in the current practice era?

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G138-G144

Published in Volume 6 Supplement G, May 2010

Current state of the absorbable metallic (magnesium) stent

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F94-F97

Published in Volume 5 Supplement F, December 2009

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F36-F42

Published in Volume 5 Supplement F, December 2009

Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents

EuroInterv.2009;4:481-484

Published in Volume 4 Number 4, January 2009

The Endeavor Stent System: will it be the next kid in the block? Numero uno, first among equals or equal?

EuroInterv.2005;2:123-124

Published in Volume 1 Number 2, August 2005